Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice

Fig. 2

Generation and characterization of mesenchymal stem cells (MSC) from human embryonic stem cells (hESCs). a The typical morphology of hESC-MSC. Scale bar = 100 μm. b Karyotype of MSCs. c Surface antigen profiling in hESC-MSC by FACS. TRA-1-60 and SSEA4 are markers of pluripotency, CD34 and CD45 are hematopoietic markers, and CD29, CD44, CD90, and CD105 are MSC markers. d hESC-MSCs have the capacity to differentiate into adipocytes, osteocytes, and chondrocytes. Experimental details are described in Supplementary Methods. Magnified images of each differentiation are shown at the bottom. Scale bar = 100 μm

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512